Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/8014
Title: Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
Authors: Catto, JWF
Robinson, MC
Albertsen, PC
Goepel, JR
Abbod, MF
Linkens, DA
Davis, M
Rosario, DJ
Warren, AY
Varma, M
Griffiths, DF
Grigor, KM
Mayer, NJ
Oxley, JD
Deshmukh, NS
Lane, JA
Metcalfe, C
Donovan, JL
Neal, DE
Hamdy, FC
Keywords: Prostate cancer;Unifocal;Regional ablation;Prostatectomy
Issue Date: 2011
Publisher: Nature Publishing Group
Citation: British Journal of Cancer, 105(7), 931 - 937, 2011
Abstract: Background: Contemporary screening for prostate cancer frequently identifies small volume, low-grade lesions. Some clinicians have advocated focal prostatic ablation as an alternative to more aggressive interventions to manage these lesions. To identify which patients might benefit from focal ablative techniques, we analysed the surgical specimens of a large sample of population-detected men undergoing radical prostatectomy as part of a randomised clinical trial. Methods: Surgical specimens from 525 men who underwent prostatectomy within the ProtecT study were analysed to determine tumour volume, location and grade. These findings were compared with information available in the biopsy specimen to examine whether focal therapy could be provided appropriately. Results: Solitary cancers were found in prostatectomy specimens from 19% (100 out of 525) of men. In addition, 73 out of 425 (17%) men had multiple cancers with a solitary significant tumour focus. Thus, 173 out of 525 (33%) men had tumours potentially suitable for focal therapy. The majority of these were small, well-differentiated lesions that appeared to be pathologically insignificant (38–66%). Criteria used to select patients for focal prostatic ablation underestimated the cancer's significance in 26% (34 out of 130) of men and resulted in overtreatment in more than half. Only 18% (24 out of 130) of men presumed eligible for focal therapy, actually had significant solitary lesions. Conclusion: Focal therapy appears inappropriate for the majority of men presenting with prostate-specific antigen-detected localised prostate cancer. Unifocal prostate cancers suitable for focal ablation are difficult to identify pre-operatively using biopsy alone. Most lesions meeting criteria for focal ablation were either more aggressive than expected or posed little threat of progression.
Description: This article is available through a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. Copyright @ 2011 Cancer Research UK.
URI: http://www.nature.com/bjc/journal/v105/n7/full/bjc2011314a.html
http://bura.brunel.ac.uk/handle/2438/8014
DOI: http://dx.doi.org/10.1038/bjc.2011.314
ISSN: 0007-0920
Appears in Collections:Electronic and Computer Engineering
Cancer
Dept of Electronic and Computer Engineering Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf316.35 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.